A gene expression-based test identifies patients with primary cutaneous melanoma at a lower or higher risk for sentinel lymph ...
Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor ...
Sharon McLucas, 55, from St Helier, said she had a "gut instinct" something was wrong when she noticed a change on her leg ...
The Trump administration has undermined the once bipartisan war on cancer and declined to approve a promising melanoma ...
Get the latest analysis on Iovance Biotherapeutics (IOVA): dilution risks, missed revenue, and margin outlook. Click here to ...
Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor protein 1 (FSP1)—a ...
HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a ...
Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...
CytomX Therapeutics, Inc.'s ADC candidate, CX-2051, shows promise in colorectal cancer. Click here to read an analysis of ...
Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback